Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease.
Ostrominski JW, Højbjerg Lassen MC, Claggett BL, Miao ZM, Inzucchi SE, Docherty KF, Desai AS, Jhund PS, Køber L, Ponikowski P, Sabatine MS, Lam CSP, Martinez FA, de Boer RA, Hernandez AF, Shah SJ, Petersson M, Langkilde AM, McMurray JJV, Solomon SD, Vaduganathan M.
Ostrominski JW, et al. Among authors: mcmurray jjv.
Eur Heart J. 2024 Nov 21:ehae780. doi: 10.1093/eurheartj/ehae780. Online ahead of print.
Eur Heart J. 2024.
PMID: 39568016